This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …

This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …

For over two decades, the EBMT has updated recommendations on indications for
haematopoietic cell transplantation (HCT) practice based on clinical and scientific …

Our understanding of the pathophysiology of aplastic anemia is undergoing significant
revision, with implications for diagnosis and treatment. Constitutional and acquired disease …

Dyskeratosis congenita is a rare hereditary disease that occurs predominantly in males and
manifests clinically as the classic triad of reticulate hyperpigmentation, nail dystrophy and …

Dyskeratosis congenita (DC) is an inherited bone marrow failure (BMF) syndrome
characterized by the classic triad of abnormal skin pigmentation, nail dystrophy, and oral …

Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …

We describe outcomes after allogeneic transplantation in 34 patients with dyskeratosis
congenita who underwent transplantation between 1981 and 2009. The median age at …

Dyskeratosis congenita (DC) is a genetic multisystem disorder with frequent involvement of
the bone marrow. Haematopoietic stem cell transplantation (HSCT) is the only definitive cure …

Dyskeratosis congenita (DC) is a rare, inherited bone marrow failure (BMF) syndrome
characterized by variable manifestations and ages of onset, and predisposition to cancer …